Abdel-Halim, Heba
1086  Ergebnisse:
Personensuche X
?
2

Identification of Drug Combination Therapies for SARS-CoV-2..:

Abdel-Halim, Heba ; Hajar, Malak ; Hasouneh Jnr, Luma.
Drug Design, Development and Therapy.  16 (2022)  - p. 2995-3013 , 2022
 
?
 
?
5

The search of potential inhibitors of the AcrAB–TolC system..:

Abdel-Halim, Heba ; Al Dajani, Ala'a ; Abdelhalim, Abeer.
Applied Microbiology and Biotechnology.  103 (2019)  15 - p. 6309-6318 , 2019
 
?
6

Phytochemical analysis and antidiabetic potential of Elaeag..:

Nazir, Nausheen ; Zahoor, Muhammad ; Nisar, Mohammad...
BMC Complementary and Alternative Medicine.  18 (2018)  1 - p. , 2018
 
?
 
?
10

Modelling of molecular phase transitions in pharmaceutical ..:

Abdel-Halim, Heba ; Traini, Daniela ; Hibbs, David..
European Journal of Pharmaceutics and Biopharmaceutics.  78 (2011)  1 - p. 83-89 , 2011
 
?
11

QSPR modeling of pseudoternary microemulsions formulated em..:

Taha, Mutasem O. ; Abdel-Halim, Heba ; Al-Ghazawi, Mutasim.
International Journal of Pharmaceutics.  295 (2005)  1-2 - p. 135-155 , 2005
 
?
13

Identification of Drug Combination Therapies for SARS-CoV-2..:

Abdel-Halim, Heba ; Hajar, Malak ; Hasouneh, Luma.
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S366423.  , 2022
 
?
14

2-Aminoethyl Methylphosphonate, a Potent and Rapidly Acting..:

Xie, An ; Yan, Jun ; Yue, Lan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228531.  , 2011
 
?
 
1-15